SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-023264
Filing Date
2020-08-21
Accepted
2020-08-21 16:09:06
Documents
2
Period of Report
2020-08-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2273
2 POWER OF ATTORNEY ea125837ex24_kintara.htm EX-24 5352
  Complete submission text file 0001213900-20-023264.txt   9140
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6275 NANCY RIDGE DRIVE, SUITE 110 SAN DIEGO CA 92121
Business Address
Murphy Keith (Reporting) CIK: 0001536583 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37823 | Film No.: 201123501